RMAM001 Breast cancer cell line
Contributors
| Inventor | Institute |
|---|---|
| Medical-Industrial Translational Research Center | Fukushima Medical University |
| SKU: | 160989 |
|---|---|
| Product description: | Novel patient-derived cell lines (PDCs) have been constructed under the Fukushima Translational Research Project. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of PDCs were similar to their source tumors, even after long-term growth in culture conditions |
| Alternate name: | RMAM001, RMAM1 |
| Gender: | Female |
| Cat. #: | 160989 |
|---|---|
| Unit size: | 1 ml |
| Cancer types: | Breast cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Breast |
| Gender: | Female |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Breast cancer;Invasive carcinoma |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | Supplement, 2% B-27 Supplement, 50 ng/mL EGF, and 50 ng/mL bFGF |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Storage medium: | CELLBANKER 2 |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
Images
View Gallery
Product Images
16098920-2076520×20500-1.png
